Marinus Pharma (MRNS) Reports Q4 Loss of $0.45
Tweet
Share
E-mailGet Alerts MRNS Hot Sheet
Join SI Premium – FREE
Marinus Pharma (NASDAQ: MRNS) reported Q4 EPS of ($0.45), versus ($0.26) reported last year.
For earnings history and earnings-related data on Marinus Pharma (MRNS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- Goldman Sachs sees refinery exemptions boosting DK cash flow
- UBS Downgrades H.U. Group Holdings Inc (4544:JP) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
